| Year |
Citation |
Score |
| 2018 |
Ding K, Zhou Z, Hou S, Yuan Y, Zhou S, Zheng X, Chen J, Loftin C, Zheng F, Zhan CG. Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs. Scientific Reports. 8: 5205. PMID 29581541 DOI: 10.1038/S41598-018-23482-4 |
0.339 |
|
| 2016 |
Adedoyin OO, Loftin CD. Microsomal Prostaglandin E Synthase-1 Expression by Aortic Smooth Muscle Cells Attenuates the Differentiated Phenotype. Journal of Cardiovascular Pharmacology. PMID 27159620 DOI: 10.1097/Fjc.0000000000000395 |
0.348 |
|
| 2014 |
Oestreich JH, Steinhubl SR, Ferraris SP, Loftin CD, Akers WS. Effect of genetic variation in P2Y12 on TRAP-stimulated platelet response in healthy subjects. Journal of Thrombosis and Thrombolysis. 38: 372-9. PMID 24510678 DOI: 10.1007/S11239-014-1058-5 |
0.45 |
|
| 2013 |
Trivedi DB, Loftin CD, Clark J, Myers P, DeGraff LM, Cheng J, Zeldin DC, Langenbach R. β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice. Circulation Research. 112: 1219-29. PMID 23524589 DOI: 10.1161/Circresaha.112.280399 |
0.37 |
|
| 2012 |
Ghoshal S, Loftin CD. Cyclooxygenase-2 inhibition attenuates abdominal aortic aneurysm progression in hyperlipidemic mice. Plos One. 7: e44369. PMID 23209546 DOI: 10.1371/Journal.Pone.0044369 |
0.383 |
|
| 2012 |
Mukherjee K, Gitlin JM, Loftin CD. Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype. Journal of Cardiovascular Pharmacology. 60: 520-9. PMID 22967986 DOI: 10.1097/Fjc.0B013E318270B968 |
0.373 |
|
| 2011 |
Ghoshal S, Trivedi DB, Graf GA, Loftin CD. Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice. The Journal of Biological Chemistry. 286: 889-98. PMID 20961858 DOI: 10.1074/Jbc.M110.139139 |
0.32 |
|
| 2009 |
Kelso ML, Scheff SW, Pauly JR, Loftin CD. Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice. Bmc Neuroscience. 10: 108. PMID 19719848 DOI: 10.1186/1471-2202-10-108 |
0.312 |
|
| 2009 |
Gitlin JM, Loftin CD. Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice. Cardiovascular Research. 81: 400-7. PMID 18948273 DOI: 10.1093/Cvr/Cvn286 |
0.312 |
|
| 2007 |
Gitlin JM, Trivedi DB, Langenbach R, Loftin CD. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovascular Research. 73: 227-36. PMID 17137566 DOI: 10.1016/J.Cardiores.2006.10.015 |
0.336 |
|
| 2006 |
Trivedi DB, Sugimoto Y, Loftin CD. Attenuated cyclooxygenase-2 expression contributes to patent ductus arteriosus in preterm mice. Pediatric Research. 60: 669-74. PMID 17065565 DOI: 10.1203/01.Pdr.0000246480.13170.C0 |
0.331 |
|
| 2006 |
King VL, Trivedi DB, Gitlin JM, Loftin CD. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1137-43. PMID 16514081 DOI: 10.1161/01.Atv.0000216119.79008.Ac |
0.385 |
|
| 2004 |
Gray T, Nettesheim P, Loftin C, Koo JS, Bonner J, Peddada S, Langenbach R. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Molecular Pharmacology. 66: 337-46. PMID 15266025 DOI: 10.1124/Mol.66.2.337 |
0.301 |
|
| Show low-probability matches. |